Factors mediating pain-related risk for opioid use disorder

被引:23
作者
Nazarian, Arbi [1 ]
Negus, S. Stevens [2 ]
Martin, Thomas J. [3 ]
机构
[1] Western Univ Hlth Sci, Dept Pharmaceut Sci, 309 E Second St, Pomona, CA 91766 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll Virginia Campus, Richmond, VA 23298 USA
[3] Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA
基金
美国国家卫生研究院;
关键词
Pain; Opioid; Abuse; Reward; Cognition; Vulnerability; INTRACRANIAL SELF-STIMULATION; CONDITIONED PLACE PREFERENCE; PROGRESSIVE-RATIO SCHEDULES; POSTTRAUMATIC-STRESS-DISORDER; ENDOGENOUS BETA-ENDORPHIN; EMOTIONAL DECISION-MAKING; CORE OUTCOME MEASURES; HIGHER DISCOUNT RATES; DOSE-EFFECT FUNCTIONS; ACTIVATED G-PROTEINS;
D O I
10.1016/j.neuropharm.2021.108476
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pain is a complex experience with far-reaching organismal influences ranging from biological factors to those that are psychological and social. Such influences can serve as pain-related risk factors that represent suscep-tibilities to opioid use disorder. This review evaluates various pain-related risk factors to form a consensus on those that facilitate opioid abuse. Epidemiological findings represent a high degree of co-occurrence between chronic pain and opioid use disorder that is, in part, driven by an increase in the availability of opioid analgesics and the diversion of their use in a non-medical context. Brain imaging studies in individuals with chronic pain that use/abuse opioids suggest abuse-related mechanisms that are rooted within mesocorticolimbic processing. Preclinical studies suggest that pain states have a limited impact on increasing the rewarding effects of opioids. Indeed, many findings indicate a reduction in the rewarding and reinforcing effects of opioids during pain states. An increase in opioid use may be facilitated by an increase in the availability of opioids and a decrease in access to non-opioid reinforcers that require mobility or social interaction. Moreover, chronic pain and substance abuse conditions are known to impair cognitive function, resulting in deficits in attention and decision making that may promote opioid abuse. A better understanding of pain-related risk factors can improve our knowledge in the development of OUD in persons with pain conditions and can help identify appropriate treatment strategies. This article is part of the special issue on ?Vulnerabilities to Substance Abuse.?.
引用
收藏
页数:17
相关论文
共 238 条
[11]   Principles of drug abuse liability assessment in laboratory animals [J].
Ator, NA ;
Griffiths, RR .
DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) :S55-S72
[12]   Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice [J].
Bagdas, Deniz ;
Muldoon, Pretal P. ;
AiSharari, Shakir ;
Carroll, F. Ivy ;
Negus, S. Stevens ;
Damaj, M. Imad .
NEUROPHARMACOLOGY, 2016, 102 :236-243
[13]   Impulsivity and opioid drugs: differential effects of heroin, methadone and prescribed analgesic medication [J].
Baldacchino, A. ;
Balfour, D. J. K. ;
Matthews, K. .
PSYCHOLOGICAL MEDICINE, 2015, 45 (06) :1167-1179
[14]   Insights from Preclinical Choice Models on Treating Drug Addiction [J].
Banks, Matthew L. ;
Negus, S. Stevens .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (02) :181-194
[15]   Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration [J].
Banks, Matthew L. ;
Negus, S. Stevens .
ADVANCES IN PHARMACOLOGICAL SCIENCES, 2012, 2012
[16]   MicroRNAs: Emerging Role in the Endogenous μ Opioid System [J].
Barbierato, Massmo ;
Zusso, Morena ;
Skaper, Stephen D. ;
Giusti, Pietro .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2015, 14 (02) :239-250
[17]   Conditioned place preference: what does it add to our preclinical understanding of drug reward? [J].
Bardo, MT ;
Bevins, RA .
PSYCHOPHARMACOLOGY, 2000, 153 (01) :31-43
[18]   Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats [J].
Bauer, C. T. ;
Banks, M. L. ;
Blough, B. E. ;
Negus, S. S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (04) :850-862
[19]   DECREASED MOTIVATIONAL PROPERTIES OF MORPHINE IN MOUSE MODELS OF CANCEROUS- OR INFLAMMATORY-CHRONIC PAIN: IMPLICATION OF SUPRASPINAL NEUROPEPTIDE FF2 RECEPTORS [J].
Betourne, A. ;
Familiades, J. ;
Lacassagne, L. ;
Halley, H. ;
Cazales, M. ;
Ducommun, B. ;
Lassalle, J. -M. ;
Zajac, J. -M. ;
Frances, B. .
NEUROSCIENCE, 2008, 157 (01) :12-21
[20]   Toward a behavioral economic understanding of drug dependence: delay discounting processes [J].
Bickel, WK ;
Marsch, LA .
ADDICTION, 2001, 96 (01) :73-86